Jhunjhunwala-Backed IKS Health Looks to Acquire TruBridge for $600M

United States-based healthcare technology solutions provider Inventurus Knowledge Solutions (IKS) is reportedly in the midst of a $600 million acquisition bid for Nasdaq-listed TruBridge. The heirs of Rakesh Jhunjhunwala, who passed away recently, are supporting IKS.

Consolidating its foothold in the healthcare solutions and revenue cycle management (RCM) segment, this agreement, if finalised, will be the company's largest acquisition to date. There has been unprecedented consolidation in the industry over the last two years, which has piqued the interest of investors, who have prompted the transaction. In the next several days, an official announcement is anticipated.

IKS’ Shareholding Structure and its Operations

A total of three discretionary trusts belonging to the promoter family—Nishtha, Aryavir, and Aryaman—own 16.37% of IKS Healthcare. This company provided the Jhunjhunwala family with a 530-fold return on investment when it was listed in December 2024. In addition to the 33.57% held by IKS founder Sachin Gupta, Rakesh's widow Rekha Jhunjhunwala owns 0.23%. The company's goal is to make doctors' and PAs' administrative lives easier, and the promoter group owns 63.7% of the company.

The firm has been collaborating with US providers from its 2006 founding, when it was primarily an RCM service provider. As a component of care management as a whole, it oversees their responsibilities. These address a wide range of consumer interactions, from scheduling to handling rejections. In October 2023, IKS acquired Aquity Solutions for $200 million, which allowed it to expand its skills to include transcribing services.

Additionally, this resulted in numerous client connections, some of which have medium-term scalability potential. To support its all-cash offer and assist in refinancing the target's debt, IKS is in discussions with Citi, Deutsche Bank, and JP Morgan to secure $675 million in financing.

TruBridge's Recent Market Performance

In addition to its own healthcare IT solutions, TruBridge caters to healthcare organisations and community hospitals. The profit for the fourth quarter was just slightly lower than the sales forecast. Efforts to improve financial controls and continuing strategy evaluations preceded last month's earnings announcement. There was an increase in revenue for the 12 months ending in December, going from $342.2 million to $346.8 million. After suffering a net loss of $20.9 million, it turned a profit of $4.4 million.

Financial services and broking business Cantor Fitzgerald, based in the United States, expressed confidence in TruBridge's recovery efforts last week, reiterating its overweight ratings on the company. There have been rumours that the company is just a quarter or two away from more consistent quarterly bookings announcements, which would be great for investors' visibility. Analysts nonetheless saw good EBITDA and in-line revenue from TruBridge's quarterly results, even though the company missed revenue. In line with the company's endeavours to enhance reporting, a recent filing delay was determined to be insignificant.